Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page
- CheckyesterdayChange DetectedThere are no changes detected on the page. The content remains as previously published, including study details, eligibility criteria, and locations.SummaryDifference0.1%

- Check8 days agoChange DetectedRecruitment status updated to No longer looking for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label was reformatted and a revision note shows v3.6.0.SummaryDifference0.5%

- Check15 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, reflecting a small maintenance update to the page's documentation/versioning.SummaryDifference0.1%

- Check22 days agoChange DetectedNo textual changes were recorded for this page in the provided data; the content appears unchanged relative to the prior version.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a software update. No study content or details are modified by this change.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.2%

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.